Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2025-12-11

EMA Authorised: Darunavir Viatris (previously Darunavir Mylan) (darunavir) — Viatris Limited

View source ↗

Summary

EMA authorised the darunavir product Darunavir Viatris for HIV infections. This is the generic version of darunavir (formerly marketed as Darunavir Mylan).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Darunavir Viatris (darunavir)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Viatris Limited. Decision date: 04/12/2025